Conservative treatment of spasticity in patients with neurological disorders. A systematic review
DOI:
https://doi.org/10.31157/an.v24i2.174Keywords:
muscle spasticity, physical therapy, pharmacology, nervous system disease, reviewAbstract
Introduction: spasticity is a motor disruption that mainly affects the central nervous system, and it is usual in both children and adults as a consequence of different neurological pathologies. Spasticity is a chronic disorder, so its treatment should be as premature as possible. There are so many therapeutic possibilities as conservative treatment which is important in order to prevent deformities, improve daily activities, decrease muscular tone, keep the range of movement or decrease pain. The objective of this study is to check the effectivity of conservative treatment, as pharmacology as physical therapy, in order to improve spasticity caused by neurological disorders. Development: A systematic review was done following PRISMA standards, between february and may, 2018 in Medline, Cinahl and Scopus. The following MeSH terms were used: “muscle spasticity”, “physical therapy” and “drug therapy”. 13 studies were selected and were classified according to the neurological disorder, and its methodological quality were checked with Jadad scale. These articles analyse the application of pharmacology, physical therapy or both to treat spasticity. Conclusions: Both physical therapy with all its techniques, and pharmacology are effective in spasticity´s treatment, but the best results seems to be the combination of both.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.